日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

低 GPX4 通过可靶向的适应性 FSP1 上调驱动 TNBC 中持续的耐药性持续状态

Chaudhary Nazia, Mandal Dibita, Choudhary Bhagya Shree, Patra Sushmita, Jain Darshan, Poonia Pritam, Shaikh Shagufa, Tekalkar Siddhi, Malvankar Shivani, Shivashankar Anusha, Jog Eeshrita, Pilankar Leena, Thorat Rahul, Kailje Vaishali V, Khanna Sonal, Manna Subhakankha, Khan Bushra K, Jadhav Anjana, Sharma Kedar, Ramu Soundharya, Sahoo Sarthak, Jolly Mohit Kumar, Dalal Sorab N, Sinha Sanju, Nair Nishanth Ulhas, Ruppin Eytan, Lamballe Fabienne, Maina Flavio, Verma Nandini

14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer

14-3-3σ 将 YY1 限制在细胞质中,从而促进结直肠癌的治疗耐药性和肿瘤进展。

Lonare, Amol; Raychaudhuri, Kumarkrishna; Shah, Sanket; Madhu, Gifty; Sachdeva, Anoushka; Basu, Sneha; Thorat, Rahul; Gupta, Sanjay; Dalal, Sorab N

Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients

来自印度患者的激素受体阳性、HER2阴性乳腺癌患者来源的异种移植模型

Gandhi, Khusbhoo A; Chaubal, Rohan; Talker, Elizabeth; Aadhi, Jaya Chitra; Pandey, Shwetali; Mukhare, Rushikesh; Kadam, Anushree; Singh, Ankita; Gurav, Mamta; Parab, Pallavi; Kembhavi, Yogesh; Thorat, Rahul; Sekar, Anbarasan; Gulia, Seema; Gala, Kunal; Shetty, Nitin; Joshi, Shalaka; Kulkarni, Suyash; Shet, Tanuja; Gupta, Sudeep

Building a humane scientific future: Second Asia Laboratory Animal Day

构建人道的科学未来:第二届亚洲实验动物日

Singh, Vijay Pal; Bhardwaj, Himalaya; Shakthi Devan, R K; Thorat, Rahul

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells

更正:蛋白酶体活性增强对于先天性放射抗性残留胶质母细胞瘤细胞的长期存活和复发至关重要。

Rajendra, Jacinth; Datta, Keshava K; Farooqee, Sheikh Burhan Ud Din; Thorat, Rahul; Kumar, Kiran; Gardi, Nilesh; Kaur, Ekjot; Nair, Jyothi; Salunkhe, Sameer; Patkar, Ketaki; Desai, Sanket; Goda, Jayant Sastri; Moiyadi, Aliasgar; Dutt, Amit; Venkatraman, Prasanna; Gowda, Harsha; Dutt, Shilpee

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation.

奥希替尼用于治疗携带低频 EGFR T790M 突变的肺癌细胞

Joshi Asim, Butle Ashwin, Hait Supriya, Mishra Rohit, Trivedi Vaishakhi, Thorat Rahul, Choughule Anuradha, Noronha Vanita, Prabhash Kumar, Dutt Amit

Inhibition of SETMAR-H3K36me2-NHEJ repair axis in residual disease cells prevents glioblastoma recurrence

抑制残留病灶细胞中的SETMAR-H3K36me2-NHEJ修复轴可预防胶质母细胞瘤复发

Kaur, Ekjot; Nair, Jyothi; Ghorai, Atanu; Mishra, Saket V; Achareker, Anagha; Ketkar, Madhura; Sarkar, Debashmita; Salunkhe, Sameer; Rajendra, Jacinth; Gardi, Nilesh; Desai, Sanket; Iyer, Prajish; Thorat, Rahul; Dutt, Amit; Moiyadi, Aliasgar; Dutt, Shilpee

Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells

蛋白酶体活性增强对于先天性放射抗性残余胶质母细胞瘤细胞的长期存活和复发至关重要。

Rajendra, Jacinth; Datta, Keshava K; Ud Din Farooqee, Sheikh Burhan; Thorat, Rahul; Kumar, Kiran; Gardi, Nilesh; Kaur, Ekjot; Nair, Jyothi; Salunkhe, Sameer; Patkar, Ketaki; Desai, Sanket; Goda, Jayant Sastri; Moiyadi, Aliasgar; Dutt, Amit; Venkatraman, Prasanna; Gowda, Harsha; Dutt, Shilpee